Elimination of visceral leishmaniasis (VL) in Southeast Asia and global control of cutaneous
leishmaniasis (CL) and VL are priorities of the World Health Organization (WHO). But is the …

The control of the sand fly vectors of leishmaniasis is problematic because their larvae
develop in largely unknown terrestrial habitats making them impervious to available control …

Vector control remains a key component of many anti-leishmaniasis programs and probably
will remain so until an effective vaccine becomes available. Technologies similar to those …

Background Natural products of animals, plants and microbes are potential source of
important chemical compounds, with diverse applications including therapeutics. Endophytic …

Leishmaniasis is an intracellular protozoan infection that can lead to cutaneous,
mucocutaneous, visceral or systemic manifestations depending on the parasite species and …

Cutaneous leishmaniasis (CL) is a rising epidemic in Pakistan. It is a major public health
problem in the country especially alongside regions bordering the neighboring Afghanistan …

Background: Leishmaniasis is a widespread skin protozoan infectious disease. It is an
intracellular parasitic microorganism that develops in the body of infected female …

The antileishmanial drugs presently available have stern limitations regarding efficiency,
safety and cost that make it crucial to hunt for novel therapeutic approaches from natural …

Leishmaniasis is a parasitic disease caused by the hemoflagellate protozoa species of the
genus Leishmania (Yin et al., 2004). The reservoirs of the disease are rodents, dogs and …

Old and New World leishmaniasis are in urgent need of reevaluation of treatment guidelines
as treatment failure is an everyday growing problem. For this disease, treatment failure and …